Literature DB >> 3532098

Diagnosis, screening, and 'demoralization': epidemiologic implications.

J M Murphy.   

Abstract

The Dohrenwends have associated psychiatric screening instruments with Frank's concept of 'demoralization' through negative evidence of the criterion validity of the instruments for identifying 'diagnosable mental disorders'. New evidence from the Stirling County Study is given to suggest that absence of validity stems from symptom-enumerative scoring procedures and that concordance with clinical judgment is improved by employing diagnostic algorithms. The concepts of diagnosis and 'demoralization' are discussed, and the history of screening instruments is reviewed. It is suggested that, while 'demoralization' may be a useful concept for clinicians, it poses serious drawbacks for epidemiological research because of the assumptions it involves about etiology and outcome.

Entities:  

Mesh:

Year:  1986        PMID: 3532098

Source DB:  PubMed          Journal:  Psychiatr Dev        ISSN: 0262-9283


  4 in total

1.  Which measure of adolescent psychiatric disorder--diagnosis, number of symptoms, or adaptive functioning--best predicts adverse young adult outcomes?

Authors:  A Vander Stoep; N S Weiss; B McKnight; S A A Beresford; P Cohen
Journal:  J Epidemiol Community Health       Date:  2002-01       Impact factor: 3.710

2.  Universal Emotional Health Screening at the Middle School Transition.

Authors:  Ann Vander Stoep; Elizabeth McCauley; Kelly A Thompson; Jerald R Herting; Elena S Kuo; David G Stewart; Cheryl A Anderson; Siri Kushner
Journal:  J Emot Behav Disord       Date:  2005-12

3.  The DISSA: an abridged self-administered version of the DIS. Approach by episode.

Authors:  V Kovess; L Fournier
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1990-07       Impact factor: 4.328

4.  Socio-demographic and clinical features associated with demoralization in medically ill in-patients.

Authors:  Carlo Marchesi; Carlo Maggini
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-07-11       Impact factor: 4.328

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.